Home / Import refusals / 1FX-3607273-3/10001/1

FDA Import Refusal 1FX-3607273-3/10001/1 — Eli Lilly & Company

Eli Lilly & Company — FEI 1819470

The FDA refused shipment 1FX-3607273-3/10001/1 from Eli Lilly & Company (United States) on April 17, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 17, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61PDY74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1298628 (NAI Fri Jan 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1270621 (VAI Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1260339 (VAI Thu Mar 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229895 (NAI Wed Jan 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1217806 (VAI Fri Sep 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • SCS-3460415-4/10002/1 (Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-2845420-2/10002/1 (Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4863952-7/10001/1 (Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-3629208-1/20001/1 (Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-3862393-4/10001/1 (Wed Jan 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources